1832 Asset Management

1832 Asset Management’s Axsome Therapeutics AXSM Stock Holding History

1832 Asset Management’s Portfolio AXSM Stock Details AXSM Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$2.5M	Buy
2025 Q2	–	Sell
2025 Q1	$42.4M	Buy
2023 Q1	–	Sell
2022 Q4	$9.12M	Buy